) and biomarker functions, executing CDx tactics in the field, and contributing to product development in the diagnostics space... pathologists, executive level lab decision makers, lab personnel and other oncology multi-disciplinary team members, on relevant...
below: Challenge Brand / Sales teams on unjustified forecast change outside product performance trend. Focus on repeated...): Prepare and Provide SISO information beginning of every month for zone submission NPL & Product Portfolio: Review current...
on companion diagnostics (CDx) and biomarker functions, executing CDx tactics in the field, and contributing to product development... pathologists, executive level lab decision makers, lab personnel and other oncology multi-disciplinary team members, on relevant...
on companion diagnostics (CDx) and biomarker functions, executing CDx tactics in the field, and contributing to product development... pathologists, executive level lab decision makers, lab personnel and other oncology multi-disciplinary team members, on relevant...
. SPC Partnership: Collaborate with product development teams on SPC creation and submission, providing financial expertise... and maintain communication regarding Return on investment narratives. Executive Communication: Condense complex financial...
(CDx) and biomarker functions, executing CDx tactics in the field, and contributing to product development in the... pathologists, executive level lab decision makers, lab personnel and other oncology multi-disciplinary team members, on relevant...
) and biomarker functions, executing CDx tactics in the field, and contributing to product development in the diagnostics space... pathologists, executive level lab decision makers, lab personnel and other oncology multi-disciplinary team members, on relevant...
at all organizational levels (frontline marketing & operations professionals, mid-level leaders, and senior executive management). KEY... to exceed quota by actively prospecting via phone, email, marketing follow-up, personal relationships, and executive...
for this position will reside in the Pacific Northwest (U.S.). As an Account Executive IV, you will carry your own sales quota... professionals, mid-level leaders, and senior executive management). Vericast is a high growth company with the leading financial...
Detection commercial team at Guardant Health as a field-based Account Executive and work hand in hand with sales leadership... Account Executive – Screening is responsible for effectively promoting cancer screening colorectal cancer (CRC) liquid biopsy...
Six-time Olympic gold medallist Sir Chris Hoy tells BBC Breakfast about his life with terminal cancer and the legacy he hopes to leave. Continue Reading »
NMDC's board will evaluate a proposed bonus share issue and review financial results for the quarter ending September 2024 next week. The last bonus issue occurred in May 2008. Continue Reading »
ACME Solar Holdings, a leading renewable energy player in India, is set to go public with its IPO opening on November 6th. The company aims to raise ₹2,900 crore through a mix of fresh equity and offer for sale. Continue Reading »
Many of India’s biggest IPOs, including Hyundai Motor India, Paytm and Reliance Power have resulted in losses for investors. Only a few large IPOs — such as Coal India, Zomato, and HDFC Life Insurance — have generated positive returns, with their shares trading above the issue price. Continue Reading »
US Election 2024: Donald Trump's presidency would have a limited negative impact on Indian IT firms, while a potential Kamala Harris administration would largely maintain the current policies, said brokerage firm JM Financial. Continue Reading »
Stock market rebounds: Sensex jumped over 1,100 points from day’s low and Nifty 50 traded near the 24,200 level on November 5, rebounding from early morning losses. Continue Reading »
Muthoottu Mini Financiers Limited is raising up to ₹150 crore through a public issue of secured non-convertible debentures. The NCDs, priced at ₹1,000 each, are open for subscription from October 30 to November 13, 2024. Continue Reading »
Sagility IPO: Sagility India Ltd has launched its IPO with subscriptions open from November 5 to November 7, priced at ₹28-30 per share. The company has garnered over ₹945 crore from anchor investors, but initial bidding has seen slow traction despite strong retail interest. Continue Reading »